arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Werewolf Therapeutics, Inc.

HOWL Health Care Biotechnology: Pharmaceutical Preparations
$1.02
▼ -1.0% Today
as of Oct 23, 12:03 ET
Last 30 days +6.47% Sep 14 → Oct 23
$0.87 $0.92 $0.97 $1.01 $1.06 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.01
High
$1.05
Low
$1.00
Volume
$179,101
Avg Vol
$2M
Mkt Cap
$45M
P/E (TTM)
—
Beta
—
52w High
$1.83
52w Low
$0.27
Div Yield
—
Shares Out
$49M

Recent Press Releases & News last 60 days · 2 items

Oct 13 · 15:00 Zacks
Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why
Aug 26 · 15:47 Barchart
1 Penny Stock That Could Howl Its Way to the Top After a $150 Million Funding Boost

HOWL earnings at a glance

Werewolf Therapeutics, Inc. (HOWL) is scheduled to report earnings on Tuesday, November 3, 2026 — in 11 days. The options market is pricing a move of about ±20.4% after the report, a range of roughly $0.81 to $1.23 from today's $1.02. Over its last 6 reports the stock rose the next day 1 time and fell 5, moving ±10.7% on average; after the most recent report on Jul 31, 2026 it moved -29.4%. That means options currently expect more movement than HOWL has typically delivered. HOWL beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 98%. The share price of $1.02 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.27
$1.83
48% of range
Avg surprise (last 6)
+36.5%
Avg reaction (last 6)
-7.4%
17% positive
Latest IV / EM
98%
EM ±20.4% · $1 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.50$-0.35$-0.21$-0.07$0.08 Actual $-0.34Actual $-0.14Actual $-0.23Actual $-0.39Actual $-0.43Actual $-0.38Actual $-0.40Est $-0.44Actual $-0.40Est $-0.50Actual $-0.36Est $-0.39Actual $-0.20Est $-0.34Actual $-0.28Est $-0.32Actual $0.08Est $-0.28 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/20268K
Revenue vs Net Income Revenue Net income
$-17M$-12M$-6M$-1M$4M Sep 24Sep 25Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri Jul 31, 20268K 2026-07-31 $0.08 $-0.28 +128.6% — -29.4% earnings
Thu May 7, 2026Mar/2026 $-0.28 $-0.32 +12.5% +30.0% +9.7% earnings
Fri Mar 27, 20268K 2026-03-27 $-0.20 $-0.34 +41.2% — -9.5% earnings
Tue Nov 4, 2025Sep/2025 $-0.36 $-0.39 +7.7% — -7.6% earnings
Thu Aug 14, 2025Jun/2025 $-0.40 $-0.50 +20.0% — -2.2% earnings
Thu May 8, 2025Mar/2025 $-0.40 $-0.44 +9.1% — -5.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.38 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.43 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.39 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.23 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.14 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.34 — — — — financials
Fri Sep 30, 2022Sep 2022 $-0.40 — — — — financials
Thu Jun 30, 2022Jun 2022 $-0.53 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Nov 3, 2026Sep/2026OTHER —-$0.36

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$7M$-13M—$-16M—$-18M—$-17M
Net income$4M——$-16M———$-17M
EPS (diluted)$0.08$-0.28—$-0.36—$-0.40—$-0.38

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$22M$46M$57M$66M—$92M$111M$123M
Inventory————————
Total current assets$23M$49M$59M$68M$80M$94M$113M$126M
Total assets$24M$58M$69M$80M$93M$107M$127M$140M
Long-term debt—$32M—$32M$32M$32M—$32M
Total liabilities$8M$46M$45M$50M$51M$50M$54M$51M
Total equity$16M—$25M$30M——$73M$89M

Implied volatility — last 90 days

97%8073%16049%24024%32000% Jun 07 — IV 7821% · EM ±1083.4%Jun 08 — IV 8228% · EM ±1086.7%Jun 09 — IV 9164% · EM ±1148.2%Jun 10 — IV 9973% · EM ±1178.1%Jun 11 — IV 9872% · EM ±1090.8%Jun 12 — IV 10776% · EM ±1102.4%Jun 15 — IV 14930% · EM ±1080.0%Jun 16 — IV 19988% · EM ±1180.6%Jun 17 — IV 32000% · EM ±1336.4%Jun 19 — IV 3993% · EM ±882.4%Jun 22 — IV 4076% · EM ±851.1%Jun 23 — IV 4257% · EM ±870.9%Jun 24 — IV 4198% · EM ±840.9%Jun 25 — IV 4891% · EM ±958.1%Jun 26 — IV 5177% · EM ±990.7%Jun 29 — IV 5864% · EM ±1039.0%Jun 30 — IV 5237% · EM ±901.8%Jul 01 — IV 5427% · EM ±906.5%Jul 02 — IV 5812% · EM ±940.1%Jul 03 — IV 6016% · EM ±940.1%Jul 06 — IV 9161% · EM ±1269.0%Jul 07 — IV 9135% · EM ±1206.4%Jul 08 — IV 9650% · EM ±1209.0%Jul 09 — IV 9506% · EM ±1122.9%Jul 10 — IV 12215% · EM ±1349.7%Jul 13 — IV 18839% · EM ±1573.5%Jul 14 — IV 17677% · EM ±1278.7%Jul 15 — IV 21694% · EM ±1281.3%Jul 16 — IV 28312% · EM ±1182.4%Jul 20 — IV 6441% · EM ±1521.7%Jul 21 — IV 5213% · EM ±1212.1%Jul 22 — IV 3949% · EM ±903.4%Jul 23 — IV 3950% · EM ±888.4%Jul 24 — IV 3477% · EM ±768.3%Jul 27 — IV 3222% · EM ±672.8%Jul 28 — IV 5167% · EM ±1057.2%Jul 29 — IV 3305% · EM ±662.0%Jul 30 — IV 3214% · EM ±629.5%Jul 31 — IV 4571% · EM ±874.8%Aug 03 — IV 6501% · EM ±1151.8%Aug 04 — IV 4202% · EM ±723.6%Aug 05 — IV 8116% · EM ±1355.7%Aug 06 — IV 5909% · EM ±955.8%Aug 07 — IV 5238% · EM ±818.4%Aug 10 — IV 5953% · EM ±824.6%Aug 11 — IV 6414% · EM ±847.0%Aug 12 — IV 6792% · EM ±851.0%Aug 13 — IV 7128% · EM ±842.0%Aug 14 — IV 7268% · EM ±803.1%Aug 17 — IV 9448% · EM ±789.1%Aug 18 — IV 14358% · EM ±1038.6%Aug 19 — IV 17936% · EM ±1059.3%Aug 20 — IV 12665% · EM ±528.9%Aug 24 — IV 1696% · EM ±354.2%Aug 25 — IV 1840% · EM ±376.5%Aug 26 — IV 1596% · EM ±319.6%Aug 27 — IV 1612% · EM ±315.8%Aug 28 — IV 1717% · EM ±328.6%Aug 31 — IV 1891% · EM ±335.1%Sep 01 — IV 1767% · EM ±304.3%Sep 02 — IV 1772% · EM ±296.0%Sep 21 — IV 98% · EM ±20.4%

Sector peers

VERU
Veru Inc.
$44M $2.27-1.3%
EDSA
Edesa Biotech, Inc.
$46M $2.72-4.6%
GRCE
Grace Therapeutics, Inc.
$43M $1.90-3.5%
FLNA
Filana Therapeutics, Inc.
$47M $0.64-2.9%
CRVO
CervoMed Inc.
$48M $2.27-3.0%
NSRX
Nasus Pharma Ltd.
$40M $3.51+14.7%

HOWL earnings FAQ

When is HOWL's next earnings date?

Werewolf Therapeutics, Inc. is expected to report on November 3, 2026.

What is HOWL's expected move for earnings?

Options currently price a move of about ±20.4%, or $0.21 per share either way from $1.02.

How does HOWL stock usually react to earnings?

Across the last 6 reports the average next-day move was ±10.7%, up 1 times and down 5 times.

What is HOWL's implied volatility?

HOWL's at-the-money implied volatility is about 98% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in